Control of meningococcal meningitis outbreaks in sub-Saharan Africa

Area of Science:

• Epidemiology
• Infectious Diseases
• Vaccinology

Background:

• Recurrent Neisseria meningitidis outbreaks in the African Sahel cause significant mortality and morbidity, particularly in children.
• Existing vaccines have failed to control epidemics, and geographical distribution of N. meningitidis is expanding due to climate change and socioeconomic factors.
• Emerging serogroups like X and W135 are concerning, but serogroup A remains the most prevalent cause of meningococcal meningitis.

Purpose of the Study:

• To highlight the persistent challenge of meningococcal meningitis epidemics in the African Sahel.
• To emphasize the continued significance of serogroup A as a primary target for control strategies.
• To advocate for the development of a low-cost conjugate vaccine for preventive immunization.

Main Methods:

• Review of epidemiological data on Neisseria meningitidis outbreaks in the African Sahel.
• Analysis of factors contributing to the failure of existing control strategies.
• Assessment of the impact of climate change and socioeconomic factors on disease spread.

Main Results:

• Serogroup A remains the most common meningococcal isolate despite the emergence of other serogroups.
• Epidemics continue to cause high mortality and morbidity, especially among children.
• Existing control measures have proven insufficient to prevent recurrent outbreaks.

Conclusions:

• A low-cost conjugate meningococcal vaccine targeting serogroup A is essential.
• Preventive immunization strategies are the most effective approach to control this public health threat.
• Addressing socioeconomic factors and climate change may also be important for long-term control.